Picture of Medincell SA logo

MEDCL Medincell SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Brief: Medincell Q1 2026 U.S. Net Sales Reached $63 Million

April 29 (Reuters) - Medincell SA MEDCL.PA:

UZEDY Q1 2026 U.S. NET SALES REACHED $63 MILLION, UP 62% YEAR-ON-YEAR

ELIGIBLE FOR UP TO $105 MILLION IN COMMERCIAL MILESTONE PAYMENTS ON UZEDY SALES

EUROPEAN MAA ACCEPTANCE FOR OLANZAPINE LAI EXPECTED IN Q2 2026

Source text: ID:nBwjM4lHa

Further company coverage: MEDCL.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Medincell SA

See all news